Application 200169
- Type
- ANDA
- Sponsor
- HI-TECH PHARMA CO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LORAZEPAM | LORAZEPAM | CONCENTRATE;ORAL | 2MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200169-001 | LORAZEPAM | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | 2012-01-30 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A200169-001 | LORAZEPAM | 2MG/ML | CONCENTRATE / ORAL | AA | 2012-01-30 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200169-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200169-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200169-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A200169-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A200169-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A200169-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200169-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A200169-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A200169-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A200169-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A200169-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A200169-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A200169-001 | AA | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200169-001 | AA | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A200169-001 | AA | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A200169-001 | AA | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200169-001 | AA | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200169-001 | AA | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200169-001 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200169-001 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A200169-001 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A200169-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200169-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A200169-001 | AA | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A200169-001 | AA | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A200169-001 | AA | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dc1-3746-e054-00144ff8d46c | 2024-10-08 | Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 853c762d-0772-4f02-99ca-0bc2911f09f0 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4ab77192-8fe9-2965-e054-00144ff88e88 | 2024-07-19 | Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | a4fe8df0-3ce8-b8b8-e053-2995a90a28f4 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 50379c41-2676-590c-e054-00144ff8d46c | 2024-07-08 | Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1bcf608a-11c1-ec7d-e063-6394a90ab710 | 2024-06-26 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8aace309-f3ef-6aef-e053-2995a90aa197 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 933b5ef3-ec29-1a96-e053-2995a90a2d33 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | aac672f9-0ba7-4852-b8a7-caac9e4b1e77 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Proficient Rx LP | e9052b38-3c9f-4c84-9a0d-98bd99b9ddfd | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | e563594e-212c-4f31-92ea-294aeab45df3 | 2024-04-12 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | 4084fa74-9fd2-45ef-9d56-27bfa31d4e46 | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | e9b54e42-04cf-4c62-90e1-36f7b31a4e81 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | ba34ddd2-9a47-48bf-8e55-f05e9085e5a8 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 8e3d44fb-24b7-4552-9e95-de3bf871a88b | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | International Medication Systems, Limited | 7dda070d-7809-46c4-8592-eb4e4c509707 | 2024-03-04 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 82f79757-69f0-4a37-93a6-55b66ae86ad7 | 2024-02-06 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| LORAZEPAM | LORAZEPAM | A-S Medication Solutions | 8602cef8-167e-4a8c-b10f-fc3295a3abcc | 2024-01-21 | Boxed warning, Warnings, Adverse reactions | LORAZEPAM LORAZEPAM |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 973eff80-b2cd-42ca-8e88-e0151e691e59 | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
| Lorazepam | LORAZEPAM | Clinical Solutions Wholesale, LLC | fdc11b95-2233-42b4-b5f3-9390b5e9e1b2 | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | Lorazepam LORAZEPAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50383-705 | Lorazepam | Lorazepam | Hi-Tech Pharmacal Co., Inc. | ANDA | Current |
| 50383-705 | Lorazepam | Lorazepam | Akorn | ANDA | Current |
| 50383-705 | Lorazepam | Lorazepam | Hi-Tech Pharmacal Co., Inc. | ANDA | Current |
| 50383-705 | Lorazepam | Lorazepam | Hi-Tech Pharmacal Co., Inc. | ANDA | Current |